Glucagon-like peptides (glp-1) and treatment of respiratory...

Details Glucagon-like peptides (glp-1) and treatment of respiratory... Glucagon-like peptides (glp-1) and treatment of respiratory...

A - Human Necessities

61

K

A61K 38/00 (2006.01) A61K 38/26 (2006.01)

Patent

CA 2462543

This invention relates to the use of glucagon-like peptide (GLP-1) compounds to reduce the mortality and morbidity associated with critical illnesses wherein a patient is predisposed to or suffers from some type of respiratory distress.

La présente invention concerne l'utilisation de composés peptidiques de type glucagon (GLP-1) pour diminuer la mortalité et la morbidité associées aux maladies graves dans lesquelles un patient est prédisposé à ou souffre d'un certain type de détresse respiratoire.

Affiliated with

Also associated with

Rating

Glucagon-like peptides (glp-1) and treatment of respiratory... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Glucagon-like peptides (glp-1) and treatment of respiratory..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Glucagon-like peptides (glp-1) and treatment of respiratory... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1868064